ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,084.61
-0.26%
Dow Jones
42,840.26
1.18%
Gold vs US Dollar
2,623.175
0.00%
Brent Oil
72.72
0.00%
Bitcoin
98,705.04
0.97%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU
  6. UCB SA (UCB)

  7. UCB SA (UCB) News

UCB (UCB)

UCB SA
Date:
Sort by:
 Showing the most relevant articles for your search:EU:UCB
DateTimeSourceHeadlineSymbolCompany
19/11/202406:00GlobeNewswire Inc.Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease ActivityEU:UCBUCB SA
24/09/202405:00GlobeNewswire Inc.UCB and Biogen Announce Positive Topline Results From Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus and are Initiating Second Phase 3 Study in 2024EU:UCBUCB SA
22/03/202406:00GlobeNewswire Inc.UCB Convening Notice to the General Meeting of the Shareholders 2024EU:UCBUCB SA
22/03/202406:00GlobeNewswire Inc.UCB Convocation à l'Assemblée Générale des Actionnaires 2024EU:UCBUCB SA
24/05/202313:25GlobeNewswire Inc.ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug DeliveryEU:UCBUCB SA
24/03/202306:30GlobeNewswire Inc.UCB Convening Notice to the General Meeting of theShareholders 2023EU:UCBUCB SA
24/03/202306:30GlobeNewswire Inc.UCB Convocation à L’ Assemblée Générale des Actionnaires 2023EU:UCBUCB SA
13/12/202221:01GlobeNewswire Inc.Praxis Precision Medicines and UCB Announce Epilepsy Research CollaborationEU:UCBUCB SA
25/03/202206:00GlobeNewswire Inc.UCB SA - CONVOCATION A L’ASSEMBLEE GENERALE DES ACTIONNAIRES 2022EU:UCBUCB SA
25/03/202206:00GlobeNewswire Inc.UCB SA/NV - CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS 2022EU:UCBUCB SA
26/03/202106:00GlobeNewswire Inc.UCB SA - convocation à l'assemblée générale ordinaireEU:UCBUCB SA
26/03/202106:00GlobeNewswire Inc.UCB SA/NV - Convening notice annual shareholders meetingEU:UCBUCB SA
27/03/202006:00GlobeNewswire Inc.UCB SA : Convocation à l'assemblée générale des actionnairesEU:UCBUCB SA
27/03/202006:00GlobeNewswire Inc.UCB SA/NV : Convening notice to the general meeting of shareholdersEU:UCBUCB SA
22/03/201906:00GlobeNewswire Inc.UCB SA : Convocation à l'assemblée générale des actionnaires qui se tiendra à Bluepoint BrusselsEU:UCBUCB SA
22/03/201906:00GlobeNewswire Inc.UCB SA/NV: Convening Notice to attend the general meeting of shareholders to be held at Bluepoint BrusselsEU:UCBUCB SA
23/10/201805:00GlobeNewswire Inc.UCB and Biogen Announce Topline Results from a Phase 2b Study of Dapirolizumab Pegol in Systemic Lupus ErythematosusEU:UCBUCB SA
20/04/201811:55Cercle FinanceUCB: met la main sur un antiépileptiqueEU:UCBUCB SA
22/02/201813:42Cercle FinanceUCB: bien orienté après des résultats solidesEU:UCBUCB SA
06/11/201721:01GlobeNewswire Inc.Dermira and UCB Agree to End Collaboration Agreement for CIMZIAEU:UCBUCB SA
14/09/201712:00GlobeNewswire Inc.New CIMZIA® (certolizumab pegol) Findings Presented at European Academy of Dermatology and Venereology (EADV) CongressEU:UCBUCB SA
25/07/201705:00GlobeNewswire Inc.UCB and Dermira Announce U.S. and EU Regulatory Submissions for CIMZIA® (certolizumab pegol) for the treatment of Moderate-t...EU:UCBUCB SA
23/05/201715:57Cercle FinanceUCB: poursuit son repli après le problème d'essai clinique.EU:UCBUCB SA
22/05/201709:07Cercle FinanceUCB: plonge après des problèmes sur son Evenity.EU:UCBUCB SA
19/01/201707:00GlobeNewswire Inc.Final CIMZIA® (certolizumab pegol) Phase 3 Trial Meets Primary Efficacy Endpoint in Patients with Moderate-to-Severe Chronic...EU:UCBUCB SA
11/01/201711:11Cercle FinanceUCB: bien orienté, un analyste en soutien.EU:UCBUCB SA
08/12/201607:00GlobeNewswire Inc.Second CIMZIA® (certolizumab pegol) Phase 3 Trial Meets Co-primary Efficacy Endpoints in Patients with Moderate-to-Severe Ch...EU:UCBUCB SA
15/08/201609:27Cercle FinanceUCB: salué pour une décision de justice aux Etats-Unis.EU:UCBUCB SA
25/04/201612:54Cercle FinanceUCB: hausse de 11% du CA au 1er trimestre.EU:UCBUCB SA
08/03/201613:56Cercle FinanceUCB: miné par une dégradation de broker.EU:UCBUCB SA
 Showing the most relevant articles for your search:EU:UCB

Your Recent History

LSE
MARS
Marston's
LSE
BARC
Barclays
LSE
GEX
Georgina Energy
LSE
SYME
Supply@me Capital
LSE
AAZ
Anglo Asian Mining
LSE
VAST
Vast Resources
LSE
CARD
Card Factory
LSE
QBT
Quantum Blockchain Techn...
LSE
GBP
Global Petroleum
LSE
TAVI
Tavistock Investments
LSE
THX
Thor Explorations
LSE
TW.
Taylor Wimpey
LSE
PXC
Phoenix Copper
LSE
RPI
Raspberry Pi
LSE
SRSP
Sirius Petroleum
LSE
SFR
Severfield
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads